Previous close | 10.95 |
Open | 11.03 |
Bid | 11.14 x 100 |
Ask | 11.20 x 900 |
Day's range | 10.93 - 11.25 |
52-week range | 3.06 - 11.27 |
Volume | |
Avg. volume | 2,895,849 |
Market cap | 2.592B |
Beta (5Y monthly) | 0.48 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.02 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.00 |
Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Adma Biologics (ADMA) concluded the recent trading session at $10.84, signifying a -1.54% move from its prior day's close.
In the most recent trading session, Adma Biologics (ADMA) closed at $10.71, indicating a +0.85% shift from the previous trading day.